Why IPH
Delivering Invaluable Clinical Research Data
to Optimize the Continuum of Care
Enabling Enhanced, Data-Driven Decision-Making
for Quality Patient Care
IPH leverages a large, proprietary network of specialty healthcare providers to aggregate multi-domain, objective data that is GxP compliant – enabling enhanced, data-driven decision-making for pharmaceutical companies, payers, clinicians, and researchers.
Pharma
Address your pipeline targets with meaningful, real-world data for comparative efficacy research to maximize the entire pharmaceutical lifecycle, from development through market maturation.
Payers
Access invaluable clinical data to inform disease trajectories, identify effective therapies, and target opportunities for preemptive intervention.
Clinicians
Gain unparalleled insight into the efficacy of therapies for your patients with objective digital assessments, population data, and machine learning algorithms available at your fingertips.
Researchers
Leverage access to raw, de-identified, GxP-compliant data to inform research priorities, chart trajectories of disease, and pinpoint unmet patient needs.
Interested in Learning More About IPH’s Dataset?